Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
6,500,794
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
19,046,380
-
Shares change
-
-2,157
-
Total reported value, excl. options
-
$10,228,086
-
Value change
-
-$6,915
-
Number of buys
-
9
-
Number of sells
-
10
-
Price
-
$0.5370
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX) as of Q2 2024
As of 30 Jun 2024 Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,046,380 shares of stock of the company.
Largest 10 holders included TYBOURNE CAPITAL MANAGEMENT (HK) LTD, PERCEPTIVE ADVISORS LLC, BVF INC/IL, Cable Car Capital LLC, FRED ALGER MANAGEMENT, LLC, FARALLON CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Inc..
This table shows 32 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.